Study of NM8074 in Adult C3 Glomerulopathy Patients
Clinical trial NCT05647811 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05647811
- Sponsor
- NovelMed Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-05-01
- Primary completion
- 2029-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.